What Are The Risk Factors For Spectrum Pharmaceuticals Inc. (SPPI)?

As of Friday close, Spectrum Pharmaceuticals Inc.’s (NASDAQ:SPPI) stock was up $0.12, moving up 13.28 percent to $1.06. The average number of shares traded per day over the past five days has been 2,281,040 shares. 5 times new highs have been achieved over the past 5 days, with a $0.2470 gain in that time frame. In the last twenty days, the average volume was 1,377,910, while in the previous 50 days, it was 2,117,940.

Since last month, SPPI stock rose 25.13%. Shares of the company fell to $0.7710 on 07/12/22, the lowest level in the past month. A 52-week high of $3.25 was reached on 01/03/22 after having rallying from a 52-week low of $0.60. Since the beginning of this year, SPPI’s stock price has dropped by -16.54% or -$0.2100, and marked a new high 1 time. However, the stock has declined by -67.38% since its 52-week high.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Spectrum Pharmaceuticals Inc. (SPPI) last reported insider trading activity 44 days ago on Jun 23. LEBEL FRANCOIS, the Chief Medical Officer of the company, disposed of 6,667 shares for $0.84 on Jun 23. It resulted in a $5,594 divestment by the insider. LEBEL FRANCOIS sold 6,096 shares at an average price of $0.81 on Jun 22. The insider now owns 651,457 shares following the transaction. On Jun 21, EVP & CFO Brennan Nora sold 3,569 shares at $0.79 apiece. The transaction was valued at $2,802.

Financial Health

In the three months ended March 30, Spectrum Pharmaceuticals Inc.’s quick ratio stood at 2.40, while its current ratio was 2.40, showing that the company is able to pay off its debt.

According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. While analysts expected Spectrum Pharmaceuticals Inc. to report -$0.19 quarterly earnings, the actual figure was -$0.09 per share, beating the consensus estimate by 52.60%. During the quarter, the company generated -$13.99 million in EBITDA. The liabilities of Spectrum Pharmaceuticals Inc. were 44.8 million at the end of its most recent quarter ended March 30, and its total debt was $2.3 million. The value of shareholders’ equity is $180.09 million.

Technical Picture

This quick technical analysis looks at Spectrum Pharmaceuticals Inc.’s (SPPI) price momentum. With a historical volatility rate of 73.25%, the RSI 9-day stood at 83.47% on 05 August.

With respect to its five-day moving average, the current Spectrum Pharmaceuticals Inc. price is up by +30.38% percent or $0.2470. At present, SPPI shares trade +26.81% above its 20-day simple moving average and +48.46% percent above its 100-day simple moving average. However, the stock is currently trading approximately +49.38% above its SMA50 and -48.29% below its SMA200.

Stochastic coefficient K was 81.85% and Stochastic coefficient D was 69.15%, while ATR was 0.0696. Given the Stochastic reading of 81.93% for the 14-day period, the RSI (14) reading has been calculated as 75.92%. As of today, the MACD Oscillator reading stands at 0.0848, while the 14-day reading stands at 0.0951.

Analyst Ratings

JMP Securities launched its rating on Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI) to a Mkt outperform in a note to investors on September 17, 2020. Spectrum Pharmaceuticals Inc. (SPPI) has been rated Buy by analysts. According to 0 brokerage firms, SPPI is a sell, and 1 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Spectrum Pharmaceuticals Inc. stock as buy, with 4 recommending it as overweight.

With a median target price of $4.00, the current consensus forecast for the stock is $3.00 – $10.00. Based on these forecasts, analysts predict Spectrum Pharmaceuticals Inc. (SPPI) will achieve an average price target of $5.60.


Please enter your comment!
Please enter your name here

Hot Topics

Related Articles